Neuland Laboratories

Neuland Laboratories Dividend

The Dividend of Neuland Laboratories (NEULANDLAB.NS) as of Nov 16, 2026 is 12.00 INR. In the previous year, Dividend was 14.00 INR — a change of -14.29% (lower).

Dividend

12.00INR

YoY

-14.29%

Dividend yield

0.06 %

Last updated:

How much dividend does Neuland Laboratories 2026 pay?

According to the latest status from November 2026, Neuland Laboratories paid a total of 12.00 INR per share in dividends within the last 12 months. With the current Neuland Laboratories price of 21,100.00 INR, this corresponds to a dividend yield of 0.06 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 0.06%. The payout ratio is around 7% of earnings. The dividend has grown at 11.0% per year over the past 19 years.

Historical Neuland Laboratories Dividends

A dividend is paid times per year. Last year, the payout months were and August.

Historical Neuland Laboratories Dividends
PaydateDividend
34.00INR
12.00INR
14.00INR
10.00INR
5.00INR
3.00INR
2.00INR
2.00INR
1.20INR
2.00INR
1.50INR
1.43INR
1.15INR
2.89INR
1.65INR
0.99INR
0.83INR
1.49INR
1.24INR
1.24INR
0.99INR
1.32INR
1.49INR
2.06INR
1.56INR

The Neuland Laboratories Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
5.00 INR
Jan 1, 2023
10.00 INR
Jan 1, 2024
14.00 INR
Jan 1, 2025
12.00 INR
Jan 1, 2026
12.00 INR
Jan 1, 2027 (e)
34.00 INR
Jan 1, 2028 (e)
40.80 INR
Jan 1, 2029 (e)
48.96 INR
The Neuland Laboratories Dividend history
YEARDividendYoY
est48.96INR+20.00%
est40.80INR+20.00%
est34.00INR+183.33%
12.00INR0.00%
12.00INR-14.29%
14.00INR+40.00%
10.00INR+100.00%
5.00INR+66.67%
3.00INR-25.00%
4.00INR+233.33%
1.20INR—
0.00INR-100.00%
2.00INR0.00%
2.00INR+33.33%
1.50INR+4.66%
1.43INR+25.00%
1.15INR—
0.00INR—
0.00INR-100.00%
2.89INR0.00%
2.89INR—
0.00INR-100.00%
1.65INR—

Neuland Laboratories dividend history and estimates

In 2025, Neuland Laboratories paid a dividend amounting to 12.00 INR. Dividend means that Neuland Laboratories distributes a portion of its profits to its owners.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022 (e)
5.00 INR
1.00 INR
Jan 1, 2023
10.00 INR
0.00 INR
Jan 1, 2024
14.00 INR
0.00 INR
Jan 1, 2025
12.00 INR
0.00 INR
Jan 1, 2026
12.00 INR
0.00 INR
Jan 1, 2027
34.00 INR
0.00 INR
Jan 1, 2028 (e)
0.00 INR
40.80 INR
Jan 1, 2029 (e)
0.00 INR
48.96 INR

Is the Neuland Laboratories Dividend Safe?

Neuland Laboratories has been increasing the dividend for 0 years.

Over the past 10 years, Neuland Laboratories has increased it by an annual 19.62%.

Over a five-year period, the distribution rose by 31.95%.

Analysts expect a Dividend Increase of 68.33% for the current fiscal year.

Neuland Laboratories dividend payout ratio

In 2025, Neuland Laboratories had a payout ratio of 5.92%. The payout ratio indicates the percentage of the company's profits that Neuland Laboratories distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
10.05 %
Jan 1, 2023
7.85 %
Jan 1, 2024
5.99 %
Jan 1, 2025
5.92 %
Jan 1, 2026
6.58 %
Jan 1, 2027 (e)
10.04 %
Jan 1, 2028 (e)
8.70 %
Jan 1, 2029 (e)
7.95 %

Dividend Details

Understanding Neuland Laboratories's Dividend Distributions

Neuland Laboratories’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Neuland Laboratories's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Neuland Laboratories's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Neuland Laboratories’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Neuland Laboratories Stock analysis

What does Neuland Laboratories do? Neuland Laboratories Ltd. generates revenue through the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. The company operates in a single segment focused on active pharmaceutical ingredients (APIs) and allied services, with two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, and Labetalol, which are supplied to both domestic and international markets. The firm provides end-to-end chemistry solutions for the pharmaceutical industry, covering synthesis of library compounds, NCEs, and advanced intermediates across clinical and commercial stages. The company's primary customers are pharmaceutical firms requiring APIs and intermediates for generic drugs, with a focus on global markets. Neuland Laboratories Ltd. serves as a solution provider for chemistry needs, offering services from early-stage development to commercial production. The business model emphasizes tailored manufacturing services under CMS, alongside standardized GDS products, catering to the full lifecycle of pharmaceutical development and production. Revenue streams are derived from the sale of specific APIs like Levetiracetam and Mirtazapine, as well as custom manufacturing services for complex chemical processes. The firm's dual verticals allow it to address diverse market demands, with GDS targeting cost-effective generic drug production and CMS focusing on specialized, high-value manufacturing solutions for pharmaceutical clients. Neuland Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuland Laboratories stock

Over the past 12 months, Neuland Laboratories paid a dividend of 12.00 INR . This corresponds to a dividend yield of about 0.06 %. For the coming 12 months, Neuland Laboratories is expected to pay a dividend of 34.00 INR.

The current dividend yield of Neuland Laboratories is 0.06 %.

Neuland Laboratories pays a dividend, distributed in the months of July.

Neuland Laboratories paid dividends every year for the past 7 years.

For the upcoming 12 months, dividends amounting to 34.00 INR are expected. This corresponds to a dividend yield of 0.16 %.

Neuland Laboratories is assigned to the 'Health' sector.

In the year 2025, Neuland Laboratories distributed 12 INR as dividends.

The dividends of Neuland Laboratories are distributed in INR.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Neuland Laboratories